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Increasing evidence supports a decisive role for neuroinflammation in the
neurodegenerative process of several central nervous system (CNS) disorders. Microglia
are essential mediators of neuroinflammation and can regulate a broad spectrum of
cellular responses by releasing reactive oxygen intermediates, nitric oxide, proteases,
excitatory amino acids, and cytokines. We have recently shown that also in ex-vivo
cortical networks of neurons, astrocytes and microglia, an increased level of tumor
necrosis factor-alpha (TNF-α) was detected a few hours after exposure to the bacterial
endotoxin lipopolysaccharide (LPS). Simultaneously, an atypical “seizure-like” neuronal
network activity was recorded by multi-electrode array (MEA) electrophysiology. These
effects were prevented by minocycline, an established anti-inflammatory antibiotic. We
show here that the same inhibitory effect against LPS-induced neuroinflammation is
exerted also by natural plant compounds, polyphenols, such as curcumin (CU, curcuma
longa), crocin (CR, saffron), and resveratrol (RE, grape), as well as by the glucagon like
peptide-1 receptor (GLP-1R) agonist exendin-4 (EX-4). The drugs tested also caused
per-se early transient (variable) changes of network activity. Since it has been reported
that LPS-induced neuroinflammation causes rearrangements of glutamate transporters
in astrocytes and microglia, we suggest that neural activity could be putatively increased
by an imbalance of glial glutamate transporter activity, leading to prolonged synaptic
glutamatergic dysregulation.
Keywords: sterile inflammation, LPS, TNF-α, GLP-1, plant polyphenols, exendin-4 (EX-4), neocortical cultures,
multi-electrode array (MEA)
INTRODUCTION
Microglia are an integral part of central nervous system (CNS) networks, forming the innate
defensive system, and their pathological potential has been extensively investigated (Kettenmann
et al., 2011). In different pathologies, microglia acquire distinct functional states and, during the
disease progression, modify and change their activated phenotype. Activated microglia specifically
Gullo et al. Polyphenols and Exendin-4 Prevent Neuroinflammation
interact with neurons and influence their survival either in a
positive or in a negative direction. They can physically contact
injured neurons and remove synapses, a process termed synaptic
stripping (Kettenmann et al., 2013). Conceptually, microglial
cells not only can affect neural networks through removal of
cellular and subcellular elements and secreting cytokines, trophic
factors, and neurotransmitters (Kettenmann et al., 2011), but also
by receiving messages; in fact, they express a variety of receptors
for neurotransmitters, neuropeptides, and neuromodulators.
Thus they have also the capacity to sense neuronal activity
(Pocock and Kettenmann, 2007).
Current pharmacological interventions against
neuroinflammation have symptomatic benefits to certain
degrees, but do not prevent progressive neurodegeneration.
More recently, it has been shown that some natural substances
protect the substantia nigra dopaminergic neurons (involved in
the onset of Parkinson’s disease) through their anti-inflammatory
action. Among these are some polyphenols such as curcumin,
CU (Ojha et al., 2012), resveratrol, RE (Zhang et al., 2010; Gao
et al., 2014; Lofrumento et al., 2014), and peptide molecules such
as exendin-4, EX-4 (Kim et al., 2009; Athauda and Foltynie,
2016). Moreover, also crocin, CR, extracted from saffron,
resulted in an effective protection from macular degeneration,
a retinal disease principally related to oxidative stress and
chronic inflammation (Nam et al., 2010; Marangoni et al.,
2013). In many of these reports, sterile inflammation was
induced, microglia-released cytokine concentration increased,
but the properties of neuronal network activity were never
explored.
By using low concentrations of the purified bacterial
endotoxin lipopolysaccharide (LPS) over 6–8 h, we reproduced
in vitro a “sterile” CNS neuroinflammation in a 10,000-cell
network of neurons, astrocytes and microglia, grown on a
multielectrode array (MEA) dish, where neurons were regularly
bursting for weeks (Gullo et al., 2014). We found that an
“atypical” neuronal excitability took place causing long-lasting
bursts resembling epileptiform seizures. These slow changes
of neuronal excitability were accompanied by a simultaneous
increase in microglia-released tumor necrosis factor-alpha
(TNF-α) concentration, suggesting a crucial role of microglia,
but not of astrocytes, in this process. Both these effects
were blocked by pre-treatment with minocycline, an anti-
inflammatory antibiotic drug, which was inactive when applied
alone.
Here, we wished to examine whether the action of
minocycline on our neuron/astrocyte/microglial co-culture
system could be reproduced by the above mentioned natural
molecules as anti-inflammatory tools. By simultaneously
using an electrophysiological recording technique, such as
microelectrode arrays (MEA), and TNF-α ELISA assays,
we found that all of these molecules, depending on the
concentration used, were transiently able to modify the
balanced network activity and to imitate the blocking effects
of minocycline against LPS neuroinflammation. Furthermore,
all of the agents tested resulted in an anti-inflammatory action
at concentrations lower than those generally reported in the
literature.
MATERIALS AND METHODS
Cell Cultures
Primary cultures of cortical neurons were prepared from post-
natal mice (P1–P3) as previously described (Gullo et al., 2009).
All the procedures concerning animal handling and sacrifice
followed the Principles of Laboratory Animal Care (2010/63/UE
Directive), and were approved by the University of Milan-
Bicocca Ethics Committee and the Italian Ministry of Health
(D.Lgs 26/2014). Briefly, the cerebral cortex (excluding the
hippocampus) was removed from decapitated mice, cut into
1mm3 pieces, and digested by trypsin (0.15%) and DNAse (10
µg/ml) at 37◦C for 20 min. After enzyme digestion, cells were
mechanically dissociated by means of trituration, and plated
at densities of 600–900 × 103 cells/ml on glass coverslips (for
immunocytochemistry) or MEA Petri dishes pre-coated with
polyethyleneimine 0.1% (wt/vol) and laminin 20 µg/ml (30 µm
diameter ITO electrodes spaced 200 µm apart, Multichannels
System, Germany). After 3 h incubation, the plating medium
was replaced by neurobasal medium (NB) with B27 (Invitrogen,
Italy), glutamine 1 mM and basic fibroblast growth factor (bFGF)
10 ng/ml, and the culture was maintained at 37◦C in 5% CO2.
One-half of the medium volume was replaced every 3 days. The
cultures in MEA dishes were covered with gas-permeable covers
(MEA-MEM, Ala Scientific Instruments, Inc., USA) throughout
the culture period (12–22 days-in-vitro, DIV).
MEA Electrophysiology: Drug
Application-General Aspects
As previously described (Gullo et al., 2009), we report results
obtained within a few hours after positioning the MEA
dish into the incubator, which can be considered at the
steady-state. The recording area in our MEA dishes was ∼2
mm2, and in this area, the average number of neurons was
in the order of ∼5,000, plus about the same number of
astrocytes (see Figure 1 of Supplementary Material in Gullo
et al., 2010, at http://www/frontiersin.org/neuralcircuits/paper/
10.3389/fncir.2010.00011/). The average space between cells was
therefore relatively large. Neuroinflammation was induced by
incubating cultures with LPS, isolated and purified from E. coli
R515 by Enzo Life Sciences (Alexis Biochemicals, code 581-
007). This product does not contain detectable protein or DNA
contaminants with agonistic Toll-like receptor (TLR) activity.
Since it is a strong activator of TLR4 but it does not activate TLR2
or the other TLRs, it was considered suitable for our experiments.
The drugs to be tested were kept as frozen stock solutions in
distilled water (or DMSO <0.1%) at −20◦C, until diluted as
appropriate with MEA culture medium before each experiment.
The drugs used were: crocin (CR), the polyphenols resveratrol
(RE) and curcumin (CU), purchased from Sigma, Italy; exendin-
4 (EX-4) and the GLP-1 receptor antagonist, exendin (9–39),
purchased from Tocris, UK. All experiments were performed by
adding the drugs in volumes that were always <1% of the total
conditionedmedia volume bathing the neurons.When indicated,
a washout was carried out with a solution pre-conditioned by the
same network under control conditions.
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MEA Electrophysiology: Recordings,
Waveform Acquisition, and Sorting
We used the same procedures previously described in Gullo
et al. (2009, 2010). Briefly, analog signals sampled at 40 kHz
were recorded at 36◦C in CO2-controlled incubators using
MEA-1060BC or 1060INV pre-amplifiers (bandwidth 1–8,000
Hz, Multichannel Systems, Germany) connected to a MEA
Workstation (bandwidth 100–8,000 Hz, Plexon Inc., USA). Data
were sorted into timestamp files by the MEAWorkstation Sorter
software (MEAWS, see details below) and cleaned of artifacts
using the OFFLine Sorter program (Plexon Inc., USA). Next,
during the PCA-based waveform sorting and for multi-unit
electrodes, we applied one of the following procedures: (i) spike
removal with a Mahalanobis threshold in the range 1.8 to 1.4; we
concurrently checked that the P-value of multivariate ANOVA
sorting quality statistics was<0.01 among the identified units; (ii)
when the previous procedure led to excessive spike invalidation,
we manually removed the spikes invading the adjacent unit
ellipsoids (the latter method was very effective in decreasing the
P-values, with only a limited number of erased spikes).
Neuronal Cluster Classification
Themethod of classification into excitatory or inhibitory neurons
is described in detail in Gullo et al. (2009, 2010) and Becchetti
et al. (2012). Briefly, for each identified unit and each burst,
the following characteristics were computed in defined time
segments: the autocorrelation function (ACF), the burst duration
(BD), the spike number (SN), the spike rate (SR), the intra-
burst spike rate (IBSR), the inter-burst intervals (IBIs), and the
Fano factor (FF; Teich, 1989; Baddeley et al., 1997). We classified
the neurons on the basis of an unsupervised learning approach
consisting of data reducing principal component analysis (PCA)
based on FF as a feature (Becchetti et al., 2012), followed
by the K-means clustering procedure. The large differences in
these burst metrics was the basis for adopting FF as the best
feature to clusterize neurons. As previously described (Becchetti
et al., 2012), these procedures normally separated two statistically
different clusters composed of numbers of excitatory (∼60–90)
and inhibitory (∼15–25) neurons, whose ratio always fitted the
ratio present in the neocortex i.e., from 4 to 5 (Gullo et al.,
2010; Sahara et al., 2012). To give an approximate idea of the
computing time involved in the analysis of a 60-electrode MEA
dish with ∼100 identified neurons, the following are the typical
parameters: 20 h-long experiment, 0.5 GB memory size, 10 min
to obtain results.
Advanced Tools for Characterizing Firing
and BD Histograms
The global network burst structure was analyzed with standard
techniques as well as procedures recently developed by us (Gullo
et al., 2012). Briefly, we applied a running window of variable
duration (from 10 ms to 1 s) in order to search for the start
and end of each burst and simultaneously collecting all of the
spikes which were precisely tagged to the engaged excitatory and
inhibitory neurons, already designated as previously explained
above. In conclusion, for each spike in a generic burst, we knew
exactly which neuron fired it and how many other spikes were
fired by all of the other neurons. This had the consequence that
we could also compute for the two identified neuronal clusters
(defined above) the average propensity for firing, namely, the
average number of spikes per burst, here called “excitability”
(EXC) in each time segment of interest (shown in Figure 1A).
Normally, it is much more interesting to compare EXC data
normalized to control for both clusters, namely, normEXC. To
investigate the heterogeneity of the burst length, BD, we studied
its distribution in the form of cumulative probabilities in each
time segment of interest, cumBD, as previously done in Gullo
et al. (2014). To compare experiments, two types of plots are
shown as follows: (i) time plots where normEXC describes how
clusters change firing in the presence of drugs with respect to
control (open, , and closed, , symbols for excitatory and
inhibitory clusters, respectively). Aligned characters, attached
to the time axis, are control (c), washout (w), or drug names
(short names were: CU, CR, RE, EX-4) indicating the presence
or absence of drugs (note axis breaks necessary to zoom to
particular time segments); (ii) cumBD plots (bin 0.2 s) vs.
burst duration describing how drugs modify the distribution
of the burst lifetimes (thick continuous lines for control; open
stars for drugs; open rightward triangles, , for LPS and open
upward triangles, 1, for washout. In our previous paper (Gullo
et al., 2014), we found that, at 6–7 h after LPS application,
its action was either present or blocked if the values of two
variables, namely normEXC and cumBD95 (the value of BD
at cumBD of 95%), resulted in an increase with respect to
control beside fixed thresholds. The normEXC threshold was
+45 ± 10% (with respect to control value, in this case 1)
and cumBD threshold was +40 ± 5% (with respect to the
BD value in control computed at cumBD95). Therefore, to
highlight if drugs were able or unable to block LPS action
in the normEXC and cumBD95 plots, in the figures these
thresholds were represented by a thin straight line and an arrow
respectively.
TNF-α Concentration Measurements
In each MEA dish, small (150 µl) aliquots of the incubation
medium were collected in control and during different times
(6 and 12 h, representing the peak-time of LPS-induced
TNF-α release, Gullo et al., 2014) after the addition of LPS
(3 µg/ml) or polyphenols/crocin/exendin-4 + LPS. Samples
(50 µl) were analyzed in triplicate for murine TNF-α with
enzyme-linked immunosorbent assay (ELISA) kits (KCM3012,
Invitrogen, Italy) according to manufacturer’s instructions. The
data were expressed as pg/ml following interpolation on the
basis of a standard curve. As suggested by the manufacturer,
the inter-assay and intra-assay variability were 3.5–4.3 and
2.6–8.2%, with a lower limit of detection <3 pg/ml. During
the analysis we did not correct the data for the small
change in the total incubation medium volume resulting from
the aliquots removal. Data were analyzed using GraphPad
7.0 software employing ANOVA followed by Dunnet’s test
for group comparison. P < 0.05 was considered statistically
significant.
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FIGURE 1 | Curcumin dose-response relationship. (A) Time plot of excitability
(EXC) for inhibitory and excitatory neurons (closed and open symbols,
respectively) recorded in one exemplary dish. Data before and after the
washout time break (13 min) have different time resolution (see calibration
bars). The time course of curcumin (CU) application is described above the
bottom line as follows: c, w, control and washout; numbers are [CU] in nM and
µM as indicated. (B) Same data as in (A), but values were normalized to those
of control and superimposed in order to be compared. Note that in this
experiment, CU either decreased the excitability of both inhibitory and
excitatory cells in the 1–30 nM concentration region or increased excitability in
the further 30–1,000 nM concentration region, in a reversible manner. (C) Plot
as in (B), but average of data from four independent experiments from different
dishes but similar DIVs.
Data Analysis and Statistical Significance
All of the data are expressed as mean values ± SEM, with n
indicating the number of experiments. We used OriginPro 9.1
to test normality of data such as cumBD and FSH. Moreover,
for statistical significance among cumBD and FSH distributions
from different experiments, we used the non-parametric tests
Wilcoxon signed rank test or Kruskal–Wallis test both available
from OriginPro 9.1. The data were analyzed and the figures
prepared using OriginPro 7.0 or OriginPro 9.1 software.
RESULTS
To study the activity of reverberating cortical networks, we
followed the procedures described in Gullo et al. (2014). In
our cultures, neurons, astrocytes and microglial cells survived
together for weeks. In these conditions, neurons were able to
generate spikes, which were stably recorded by MEA system (60
recording electrodes, 200 µm apart). The spikes were acquired
during each burst (every∼10 s) consisting of an∼1 s-brief period
of synaptic-mediated global network activity among all excitable
cells. Indeed, each elicited spike was the result of the temporal and
spatial summation of aminimumof∼100 postsynaptic potentials
reaching each of the ∼3,500 neurons present in the dish. On the
whole, each burst was a reverberating event of the spontaneous
network activity consisting of a total of ∼600 spikes elicited by
neurons (∼75 and ∼25 excitatory and inhibitory cells, at ∼4
and 12/burst, respectively). This means that data recorded from
a single burst were the outcome of ∼60,000 synaptic events,
but it should be kept in mind that this was a significant (n =
∼100 electrodes) sample compared to the∼3,500 interconnected
neurons present in the whole network.
When the culture dishes reached maturation (from 10 up
to 22 DIV) we performed experiments, lasting more than ∼15
h, during which no significant changes in network activity
were observed under control conditions. These cultures were
therefore useful for acquiring data in the long-lasting test on
the LPS effects, in which we recorded the atypical “seizure-like”
activity (Gullo et al., 2014). To study the neuronal activity, we
analyzed firing data by using two variables fully describing the
temporal changes: (a) plots of normEXC (excitability normalized
to control) of the clusters of excitatory and inhibitory neurons
and (b) plots of cumBD (cumulative distribution of the burst
durations). Since we found that the drugs were able to induce
relatively fast, but transient effects (compared to control data
and long-lasting LPS effects, see Gullo et al., 2014), we analyzed
results in graphs whose time axis contained appropriate breaks
and drug labels. Moreover, to decide if the LPS action should be
considered successful or blocked by drugs, we fixed thresholds
in normEXC and cumBD95 (the value of BD at cumBD of 95%)
plots as a thin straight line and a vertical arrow, respectively
(see Section Advanced Tools for Characterizing Firing and BD
Histograms). Drugs were always tested, before applying LPS, by
a brief preconditioning (30–60 min) interval in which a drug was
added to the incubation medium.
Are Drugs Intrinsically Affecting
Excitability?
For each tested drug, we performed a dose-response curve using
concentrations based on published data, and then we verified
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if the substances per-se introduced relevant excitability changes
with respect to control and washout.
In Figure 1, we show some specific exemplary experiments
for CU; similar experiments were done also for the other drugs.
As shown in Figure 1A (an exemplary experiment out of 4
similar results), the CU dose-response relationships consistently
confirmed that in the low nanomolar region, both excitatory and
inhibitory neurons decreased their activity immediately (over a
few minute time course). On the contrary, in the region from 30
nM up to 1 µM the CU effect was opposite. Finally, the effects
were almost completely reversible on washout. This plot shows
the time course of the average spikes/burst elicited by neurons
engaged in the activity (“excitability,” EXC, see details in Section
Methods) by the two inhibitory (in control ∼20) and excitatory
(∼4.5) neuronal clusters. EXC is characterized by values that
are very different between the clusters and can be changed by
pharmacological manipulations (see Becchetti et al., 2012). The
neuronal clusters responded immediately and differently after
each drug application (10 min) starting from 1 nM up to 1 µM
(see legend).
To compare different experiments, it was necessary to
normalize data to the control data, and in Figures 1B,C these
plot-types (now of “normEXC”) are shown superimposed. It can
be noticed that from the response in B, the IC50 for inhibitory
neurons (closed square) was ∼3 nM with a saturation after
10 nM and a recovery during washout. In Figure 1C we show
the average of 4 similar experiments and the normEXC dose-
response curves were found to have two different shapes in the
two concentration regions from 1 to 30 nM and from 0.1 to 1
µM, respectively. In the first region only inhibitory cells were
inhibited, and the IC50 was 4.5 ± 0.6 nM; on the contrary, in
the second region, inhibitory cells recovered their activity and
excitatory cells increased their activity. On average, at 1 µM,
the global effect was an increase of activity that recovered on
washout. It has previously been shown that an early and fast effect
of CU, characterized by an IC50 in the micromolar range, consists
of inhibiting glutamate (glu) release from synaptosomes from rat
cortex nerve endings (Lin et al., 2011, 2012).
On the whole, these results are only partially in line with
those obtained by Lin et al. (2011) by using a different
technique. Indeed, since in the cortex microcircuits, inhibitory
neurons receive glutamatergic synaptic inputs (in both feedback
and feedforward loops, see Isaacson and Scanziani, 2011), we
expected to observe a consistent decrease in their activity only
in the lower CU concentration region. Compared to those of
Lin et al. (2011) (glutamate release from synaptosomes), our
methods were characterized by the functional synapse integrity
and the astrocyte-mediated [glu]o uptake (Wanke et al., 2016),
suggesting a much higher sensitivity. Moreover, our dose-
response curves cannot be considered at steady-state because
each drug concentration was changed every 10 min.
Transient and Long Term Effects of CU:
LPS-Induced Inflammation Is Blocked at
1µM CU
Since our experiments with LPS-induced inflammation imply
very long time-segments of the order of about 18 h, we
investigated if the inhibitory CU effects seen in Figure 1 were
indeed transient and therefore eventually negligible over this
time-frame. Moreover, we wanted to use CU concentrations
lower than those that have been recently used in animals (∼100
µg/Kg/day, see Ojha et al., 2012; Hoppe et al., 2013; Zhu et al.,
2014) approximatively equivalent to ∼100 µM. Indeed, since we
did not have any blockade induced by the blood brain barrier
(see Wang et al., 2016) and the drug action should be directly on
neurons, we decided to fix 1 µM as a reasonable concentration,
which is in line with the cited experiments performed by Lin et al.
(2011).
Experiments were done by sequentially recording activity in
control (3 h), during a preconditioning in CU (about 1 h at
1 µM) and successively in LPS (at least 7 h at 3 µg/ml); a
final washout of 5 h was also recorded. The fast effects of a
single drug application were studied in detail by averaging data
every 15 min. After 3 days, in the same dish we performed
a standard experiment by applying only LPS to be sure that
the effects of the induced inflammation were still working. The
results of such a dual experiment are shown in Figures 2A–D,
respectively. In the experiment of Figure 2A that plots normEXC,
1 µM CU produced a fast and transient activity increase which
actually decayed in ∼45 min. In the inset are shown the original
data before normalization: we specifically analyzed the average
number of spikes elicited in each burst and in each cluster of
neurons; this analysis was performed counting for each neuron
the spikes engaged in each burst. In the first 15 min, the
drug caused an immediate firing increase of the inhibitory and
excitatory clusters from 25.4 ± 1.5 to 38.9 ± 2.2 and from 5.5
± 0.2 to 8.73 ± 0.4 spikes/burst (the bursts were 82, number of
inhibitory and excitatory cells, 21 and 74, respectively) (see other
details in legend). The subsequent LPS application, in fact, caused
a further decline of normEXC for both clusters of neurons and the
trend of normEXC for excitatory and inhibitory clusters was+14
± 3 and+9± 1% respectively, suggesting that LPS was unable to
exert its expected excitatory inflammatory function as previously
observed (Gullo et al., 2014). Indeed, as shown in Figure 2B, the
effects of a standard LPS application (3 µg/ml), done in the same
dish 3 DIV later, illustrate that, after 4 and up to 8 h, a strong
increase of the activity of excitatory neurons (+86 ± 6%) took
place, although we did not observe any effect on inhibitory cells.
The cumBD data associated with the Figures 2A,B
experiments are shown in Figures 2C,D, respectively. In C
four curves are superimposed as follows: (i) control (thick line),
(ii) CU at 15 min (line + asterisk), (iii) CU at 60 min (thin
line), (iv) LPS at 7 h (line + right-triangles). The corresponding
90% BD values were: 2.6, 3.8, 2.6, 3.7 s, respectively. These
results suggest that, as compared to control, CU only transiently
increased cumBD90%, and LPS over 7 h produced only a 37%
increase, confirming that the expected LPS action did not take
place. Statistical significance by Kruskal–Wallis test applied
to control data and CU at 60 min resulted in a P < 0.12, and
at 7 h in LPS data resulted in P < 0.05. In contrast, as shown
in Figure 2D, a typical effect of LPS on cumBD (in the same
dish) was to further right-shift, with respect to control (line,
95% at 7.2 s), the curves at 5 h (right-triangles) and at 9 h
(upward-triangles) to 12 s (+66%) and 17 s (+136%) values,
respectively, with “seizure-like” burst durations reaching 22 s.
Frontiers in Neuroscience | www.frontiersin.org 5 September 2017 | Volume 11 | Article 500
Gullo et al. Polyphenols and Exendin-4 Prevent Neuroinflammation
FIGURE 2 | Short- and long-term effects of curcumin in networks treated with LPS. Results from two different experiments, performed in the same dish, with
preconditioning or not-preconditioning with 1 µM curcumin (CU) (done 3 DIV later) before the application of LPS (3 µg/ml) are shown in (A,C) and (B,D), respectively.
(A) Plots of normEXC in control (c), 1 µM CU (CU), LPS (L), and during washout (w). Inset: for the brief (∼3 h) initial time segment in control, CU and L, plot of average
number of spikes/burst observed in neurons of both clusters. The continuous line is the fixed threshold. Other details: the total number of spikes from excitatory
(inhibitory, in parenthesis) neurons in control and CU (in bold): 304.2 ± 18, 568.5 ± 32 (481.9 ± 33, 764.7 ± 45.4); the total number of engaged excitatory (inhibitory,
in parenthesis) neurons was in control: 52 ± 1.8, 63.8 ± 1.1 (17.8 ± 0.3, 19.3 ± 0.2). (B) In the same dish as in (A), but 3 DIV later, plots of normEXC in control (c),
LPS (L) and during washout (w). The continuous line is the fixed threshold. (C) Plots of cumBD in different time regions of the experiment shown in (A). Data of cumBD
are superimposed as explained in text. (D) Plots of superimposed cumBD curves in different time regions of the experiment shown in (B). Note that pre-conditioning
with CU prevented the late, prolonged excitatory response to LPS. The vertical arrow indicates the fixed threshold.
The Kruskal–Wallis test of significance applied to control data
and LPS data resulted in P-values which were always smaller
than 10−4.
On the whole, these results demonstrate that 1 µM CU
by itself suddenly produced changes of activity in bursting,
by promoting long BD values and significant increases in
the excitability of both neuronal clusters. These transient
modifications rapidly returned to quasi-control values as if the
effects were partially compensated, only producing scarce or null
effects in the early hours after adding LPS. On all of the occasions
(n = 10) in which we performed these types of experiments, the
results were similar. In other experiments (n = 5) in which we
used smaller CU concentrations (i.e., 0.1 µM), the results were
not clear and these data were discarded. Few (n= 4) experiments
performed in dishes whose LPS responses were not significant
were also discarded.
Transient and Long Term Effects of CR:
LPS-Induced Inflammation Is Blocked at
20 µM CR
Crocin and crocetin have been found to block the release of NO
and various chemokines under the action of LPS (Nam et al.,
2010). As for curcumin, we did fast dose-response experiments
initially to test putative effects of crocin (CR) on the activity
of our networks (Supplementary Figure 1). In the range 1–100
µM, some inhibitory effects were seen only beyond 20 µM (n
= 3). We here show that during the first hour of incubation,
experiments using CR at 3 (n= 3) and 20 µM (n= 3) had either
negligible or transient inhibitory effects, respectively. These CR
effects were accompanied by other different actions caused by the
further LPS presence.
In Figure 3 are shown the results from two exemplary
experiments at 3 (Figures 3A,C) and 20 (Figures 3B,D) µMCR,
respectively. At 3 µM it can be observed in Figure 3A that the
early CR-induced activity was barely modified and LPS induced
a very slow, but sizeable increase of activity up to∼52% at eighth
hours. An analysis to test the cumBD plots, shown in Figure 3C,
suggests that a significant increase by 46% of BD was present at
7 h LPS as compared to control.
On the contrary, at 20 µM CR, the effects were found to
be largely depressive. After the CR application (see Figure 3B),
we detected an early negative peak of 45 and 16%, respectively
in inhibitory and excitatory cells, but this effect decayed in the
next hour. During the next 7 h in LPS, the activity remained
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FIGURE 3 | Short- and long-term effects of crocin (CR) in networks treated with LPS. Data in (A,C) and those in (B,D) belong to the same exemplary experiment.
(A,B) Plots of normEXC data for two exemplary experiments in which the dishes were treated with crocin (CR) at 3 and 20 µM, respectively. Open and closed symbols
indicate excitatory and inhibitory neurons. The continuous line is the fixed threshold. (C) Plot of cumBD in control (thick line), in the presence of 3 µM CR (asterisks),
and during the seventh hour after the addition of LPS (3 µg/ml; right triangles). These two last curves were significantly different from the control curve with P < 0.05.
(D) Plot of cumBD in control (thick line), in the presence of 20 µM CR (asterisks), and during the 10th h after the addition of LPS (right triangles). The vertical arrow
indicates the fixed threshold. These last curves were significantly different from the control curve with P < 0.05. The highest dose of CR prevented the late excitatory
LPS responses.
stable but depressed. Furthermore, by analyzing in Figure 3D the
cumBD plots, it can be concluded that the curves shifted to the
left, suggesting that the burst durations decreased, in line with a
weaker activity of the network.
On the whole, it can be concluded that CR is able to block the
LPS-induced inflammation only at concentrations higher than
15–20 µM. Interestingly, at these concentrations, although the
fast earlier transient inhibitory effects were present, a strong
general inhibition of activity remained and was washed out only
during recovery.
Transient and Long Term Effects of RE:
LPS-Induced Inflammation Is Blocked at
1 µM RE
We studied the action of resveratrol (RE) at concentrations in
the lower micromolar range, much lower than those reported
in many papers present in the literature (Gambini et al., 2015).
As reported above for CU, also RE has been described to inhibit
the release of glutamate from nerve terminals (Chang andWang,
2009). These authors showed that the threshold to detect the
start of the inhibition was between 10 and 100 nM, but at 1 µM
the effect reached the IC50. When tested in our dishes, 200 nM
RE (Figure 4B) exerted immediately a decrease in the neuronal
firing, but the network slowly recovered after∼30 min.
Due to this reason, we decided to search for a concentration
range in which effects were either unable or able to cause changes
in the plots of normEXC and the cumBD in opposite directions.
In Figures 4A,B are shown two exemplary experiments in which
RE applied at 50 and 200 nM induced a negligible or a fast
inhibitory effect, respectively, in the normEXC plots. The average
duration of these intrinsic responses of REwere never longer than
∼45 min. The subsequent application of LPS was tested every
hour over 8 h.
In Figures 4A,B it can be observed that the development of
the response was divergent, i.e.: normEXC data either increased
in Figure 4A (at 50 nM) or decreased in Figure 4B (at 200 nM),
respectively, suggesting that the drug preconditioning produced
opposite results during the LPS action. Similar results were also
seen in other 4 dishes at 50 nM and 3 dishes at 200 nM.
The fluctuations of the activity shown in Figure 4A, during
control and RE, were not significant up to the first hour of LPS
application, whereas from 2 to 8 h in LPS, the activity increased
as expected by 71% for excitatory cells and 127% for inhibitory
cells (see in Gullo et al., 2014). On the other hand, in Figure 4B,
the normEXC slowly decayed during the following 8 h.
To complete the analysis, we computed the distribution of the
BD durations of these experiments and the results are shown in
Figures 4C,D, respectively. Although the profile properties of the
control curves (thick line) were different in the two experiments,
the data acquired during the presence of RE alone show, in both
cases, a cumBD curve (see the asterisk symbols) very similar
to control. On the contrary, comparing the last hours of LPS
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FIGURE 4 | Effects of resveratrol (50 or 200 nM) on LPS responses. Data in (A,B) and (C,D) derive from two experiments performed on a single dish at 14 or 20 DIV.
(A,B) Plots of normalized excitability following application of resveratrol (RE) 50 nM (A) or 200 nM (B) and LPS (3 µg/ml). The continuous line is the fixed threshold.
Note that in (A), the late excitatory responses to LPS were not prevented, whereas in (B) the responses were inhibited. (C,D) Plots of cumBD in the same conditions
as in (A,B). The vertical arrow indicates the fixed threshold.
(right-pointing triangles) data in Figure 4C suggest that the 90%
cumBD showed an 87% increase, and in 4 D a dramatic decrease,
thus confirming that the RE doses used in these experiments
either did not block or completely blocked the LPS action,
respectively.
In Agreement with Data Reported in
Hippocampal Pyramidal Neurons, EX-4
Triggered Fast Transient Pro-Excitatory
Responses
In hippocampal pyramidal neurons in vivo, it has been shown
that a brief (1 s) application of GLP-1 (7–36) amide, a naturally
produced active fragment of GLP-1, first rapidly increased (i.e.,
1 s) and then slowly decreased (>10 s) single unit firing activity
(Oka et al., 1999). Interestingly, these effects were inhibited
either by the specific GLP-1 receptor antagonist, exendin (9–
39) or by the specific non-NMDA glutamate receptor antagonist
6-cyano-7-nitroquinoxaline-2,3-dione (CNQX), suggesting that
the initial GLP-1 action involved a fast and transient release of
glutamate.
Our in vitro networks of cortical neurons from neonatal mice
contain fractions of excitatory and inhibitory cortical neurons,
which always fit the standard ratio of 4:1 known to be present
in adult cortex (Sahara et al., 2012). As for curcumin and crocin,
we did fast dose-response experiments to test putative effects of
EX-4 on the activity of our networks (Supplementary Figure 1).
Surprisingly, we found that in about ∼80% (n = 24) of
the experiments done using EX-4, the fast effects consisted,
as expected, of a transient, brief pro-excitability response,
but there were also some networks (∼20%, n = 6) whose
responses consisted of a transient decreased excitability. This
was probably caused by unknown heterogeneity factors intrinsic
to our cultured preparation of dissociated cells, and therefore
we excluded these experiments from the results (although they
were characterized by late LPS responses where atypical activity
was present). EX-4, from 10 up to 500 nM, elicited an early
fast excitatory response and prevented the late LPS-induced
neuroinflammation. Amongst the EX-4 experiments in which
the early effects of the drug were pro-excitable, in Figure 5 are
shown the results of two experiments, performed in the same
dish (at two different DIVs) with 10 and 500 nM EX-4 and one
experiment done at 50 nM. In Figures 5A–C are compared the
normEXC data and it is evident that concentrations differing
by 5 and 50 times indeed produced fast transient excitatory
effects, suggesting a dose-dependent mechanism of action. On
the contrary, the long-term normEXC curves at the end of
the LPS application did not show any significant change, thus
suggesting that activity of the network was not different with
respect to control. We analyzed in Figures 5D–F the related
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FIGURE 5 | The fast and slow network responses to 10, 50, and 500 nM exendin-4 or exendin-4 + LPS. Data in (A,D) and (C,F) were obtained from the same dish in
two different experiments performed 3 DIV apart. (A–C) NormEXC plot obtained with 10, 50, and 500 nM exendin-4 (EX-4) preconditioning, and 3 µg/ml LPS. The
continuous line is the fixed threshold. Note that the transient and fast increase of normEXC became progressively higher with increasing EX-4 concentration.
(D–F) CumBD plots of the experiments shown in (A–C). Control, thick line; EX-4, asterisk; rightward triangles are for the late LPS effects. The vertical arrow indicates
the fixed threshold. Note that preconditioning with EX-4 at each concentration tested, effectively prevented the development of the late excitatory responses to LPS.
cumBD histograms in control, during the early EX-4 action and
at the end of the long-term LPS action. In the three cases, the
early EX-4 histograms showed a conspicuous rightward shift of
the curves. On the contrary, the final effect of LPS was either
negligible or without atypical bursts showing a BD increase at
90% in the cumBD curves.
The GLP-1 Receptor Antagonist Exendin
(9-39) Blocked the Fast Transient EX-4
Effect and the Protective Effect against
LPS Neuroinflammation
In order to confirm that the EX-4 action shown in Figure 5
is really due to the activation of GLP-1Rs, we performed
experiments (n = 6) in which we preconditioned the EX-
4 application (50 nM) with the specific GLP-1R antagonist
exendin (9–39) at 100 nM. The results of such an exemplary
experiment are shown in Figure 6. In Figure 6A, the normEXC
plot shows that the early application of exendin (9–39) (e)
induced a very short (10 min) and small negative deflection,
followed by the application of EX-4 (E), and of LPS, which
increased the slow normEXC up to 57 ± 3%. After 7 h, the
activity stopped increasing. In Figure 6B the cumBD plots show
that the 90% value was 8.1 and 12.2 s, in control and LPS,
respectively, thus suggesting that a normal excitatory action
of LPS took place as if EX-4 was not present. On the whole,
these experiments confirm that the results shown in Figure 5
robustly indicate EX-4 as a potent agent to prevent LPS-induced
inflammation.
The Levels of TNF-α, Measured at 6 and
12h after Preconditioning with the
Polyphenols or EX-4 in LPS-Treated
Dishes, Is Negligible Compared to the
Levels Found in Non-preconditioned
Dishes
As reported in our previous paper (Gullo et al., 2014) where
we showed that minocycline blocked the microglial-release of
TNF-α induced by LPS treatment, we performed, for all the
polyphenols and EX-4, appropriate experiments to test if the
drug concentrations used in the experiments (Figures 2–5) were
able to block also TNF-α production. As shown in Figure 7,
the amount of this cytokine was, both at 6 and 12 h after
LPS treatment, significantly smaller than that found when the
preconditioning drugs were absent. On the whole, these results
confirm that the drugs used here were not only able to block the
atypical seizures induced by LPS, but also the release of TNF-α in
the network dishes.
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FIGURE 6 | The effect of the specific antagonist of EX-4, exendin (9-39).
(A) Plot of the normEXC in an experiment in which 100 nM exendin (9–39) (e)
was applied for 30 min before 50 nM EX-4 (30 min, E) and the final long-term
application of LPS (3 µg/ml). The continuous line is the fixed threshold. (B) Plot
of cumBD in control (thick line), in the presence of exendin (9–39) (closed
asterisk), or EX-4 added on top (open asterisk) and in LPS after 7 h (rightward
triangles). The vertical arrow indicates the fixed threshold. The four curves
were tested with the non-parametric Wilcoxon signed rank test analysis
(exendin (9-39) vs. control, P < 10−5; LPS 7 h vs. control, P < 10−10; EX4 vs.
exendin (9–39), P = 0.32). The GLP1-R antagonist blocked the protective
effect of EX-4 observed in Figure 5, allowing the late excitatory responses to
LPS to be expressed.
DISCUSSION
The present study is the first to demonstrate that polyphenols
and the incretin GLP-1 hormone receptor agonist exendin-4 can
mimic the anti-inflammatory action of minocycline (Yrjänheikki
et al., 1998). In particular, they were able to block the seizure-like
atypical activity caused by LPS and the concurrent TNF-α release
from microglia, triggered by the Toll-like receptor 4 (TRL4)
pathway, in a cortical co-culture of neurons, astrocytes, and
microglia. The similar hyperactivity caused by LPS incubation
was also observed with the application of a very low (60 pM)
TNF-α concentration for ∼12 h (Gullo et al., 2014), probably
because of a marked change in the expression of glutamate
FIGURE 7 | Release of TNF-α at 6 and 12 h after LPS application. The
cytokine TNF-α is released from LPS-treated networks but not from networks
pre-treated with polyphenols or exendin-4. Graph shows TNF-α concentration
6 h (filled bars) and 12 h (open bars) post-LPS (3 µg/ml) treatment with or
without curcumin (CU, 1 µM) crocin (CR, 20 µM), resveratrol (RE, 200 nM) or
exendin-4 (EX-4, 30 nM) pre-conditioning. Data are expressed as pg/ml and
represent mean ± SEM of three independent experiments. **P < 0.01
(ANOVA, Dunnet’s test).
transporters in astrocytes and microglia, as previously described
(Persson et al., 2005; O’Shea et al., 2006; Takaki et al., 2012).
The putative role of altered glutamate uptake in mediating
components of the sterile inflammation response is currently
under investigation in our cortical co-colture system (EW, FG,
and ML), which includes functional astocytes (Wanke et al.,
2016).
Roles of Microglia
Microglia are highly ramified cells which rapidly scan the
local environment and react to its modification (Davalos et al.,
2005). Under physiological conditions, microglia react rapidly
to neuronal activity by modulating the contacts that their
processes continuously establish with synaptic elements (Wake
et al., 2009). Amongst the microglial-released molecules with
a putative role in neurotransmission, TNF-α was shown to
control basal synaptic functions (Santello et al., 2011) as well
as plasticity (Stellwagen and Malenka, 2006; Costello et al.,
2011), even if this role was attributed to TNF-α produced by
astrocytes. However, the astrocytes have often been thought to
release TNF-α because cultures of astrocytes are consistently
contaminated by microglia (Saura, 2007). In fact, other data
reveal no TNFα-encoding transcript in astrocytes (Foo et al.,
2011; Zamanian et al., 2012). Thus, the TNF-α that controls
several aspects of synaptic transmission is produced bymicroglial
cells. Similarly, TLR4, the specific LPS receptor, was detected
in mixed astrocyte/neuronal cultures, but when microglia were
removed from astrocyte cultures, TLR4 expression was no longer
present (Lehnardt et al., 2002).
Polyphenols and Their Features of Action
Apart from the obvious concentration-dependence, the effects
of polyphenols can be subdivided into various types of action
according to: (i) time-dependence (fast or long-term), (ii)
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cell-dependence (nervous or non-nervous system), and (iii)
disease-dependence (i.e., Parkinson’s, Alzheimer’s diseases, or
cancer). CU was found to be neuroprotective in the MPTP
model of Parkinson’s disease (Ojha et al., 2012) by inhibiting
the generation of pro-inflammatory cytokines through the
prevention of NF-κB traslocation into the nucleus (Karunaweera
et al., 2015). In addition, CU attenuated inflammation in
experimental traumatic brain injury (Zhu et al., 2014) and
decreased human TNF-α levels (Sahebkara et al., 2016). The
nanoencapsulated CU version was also found to reduce β-
amyloid-induced cognitive impairment in rats (Hoppe et al.,
2013). In the same way as CU, RE was also able to protect
dopamine neurons (Zhang et al., 2010) from LPS-induced
inflammation. Moreover, RE was found to protect cortical
neurons from oxygen-glucose deprivation-induced apoptosis
(Gao et al., 2014). In general, RE studies in in vitro and in
vivo showed interesting data of metabolism and bioavailability in
various animal models and in humans (Smoliga and Blanchard,
2014; Gambini et al., 2015). Interestingly, RE was shown to
ameliorate the clinical severity observed in an animal model of
multiple sclerosis, by maintaining the integrity of the blood-brain
barrier (Wang et al., 2016). In summary, we believe that the
principal mechanisms by which polyphenols were able to protect
against LPS neuroinflammation in our system are those related to
the TLR4 pathway and microglia activation.
The Action of GLP-1 in the CNS
There is evidence that the gut hormone GLP-1 is also produced
in the brain (Korol et al., 2015; Thiebaud et al., 2016). In
particular, it was shown that the GLP-1 receptor agonist exendin-
4 (EX-4) protected dopaminergic neurons by inhibiting TNF-
α release from microglia (Kim et al., 2009). A reduction of
brain TNF-α levels was also described in an animal model of
Alzheimer disease (AD) exposed to EX-4 treatment (Solmaz
et al., 2015). In LPS-treated rats, GLP-1 protected hippocampal
neurons from synaptic impairments (Iwai et al., 2014) and
inhibited IL-1β production from cultured astrocytes (Iwai et al.,
2006). Furthermore, in vitro administration of EX-4 in rats
increased the expression of the astrocytic glutamate transporter
GLT-1 in the hippocampus, lowering extracellular glutamate
concentration (Kobayashi et al., 2013). This is in line with
the lower long-term excitability data shown in Figures 5B,C
during LPS inflammation. The results shown in Figures 5, 6
split the presumed fast AMPAR-induced transient firing increase
following GLP-1R activation (by EX-4), as characterized by Oka
et al. (1999), from the long-term effects related to the switch-off
of the LPS-induced inflammation.
Our data show, quite importantly, and for the first time, that
these effects are not peculiar to the hippocampus in vivo, but
can also be reproduced in vitro, in networks from neocortical
dissociated cells containing neurons, astrocytes, and microglia.
Moreover, the data shown in Figure 6 demonstrate that the GLP-
1R antagonist exendin (9–39) functionally blocked the ability
of EX-4 to counteract the LPS sterile inflammation. Thus in
summary, we think that the intriguing connection between
the fast electrophysiological responses and the slow microglia
pathway merits a specialized investigation, difficult to be carried
out by means of our procedures.
Ion Channels in Microglia
Only recently, ion channels have also been described to be
functionally expressed in microglia (for a minireview, see Madry
and Attwell, 2015). Among the various types of identified
channels, the voltage-gated proton channel Hv1 (not present in
neurons) was thought to have a dramatic importance during
damage induced by ischemic stroke when reactive oxygen species
(ROS) are generated (Wu et al., 2012). Accordingly, knock-
out mice lacking the Hv1 channel were protected from ROS-
mediated neuronal death and brain damage. Furthermore, since
acute neuroinflammation provokes intracellular acidification
(Tyrtyshnaia et al., 2016), it cannot be excluded that voltage-gated
proton channels or acid-sensing channels (Yu et al., 2015) could
also be involved in this type of process. Indeed, a polyphenol such
as epigallocatechin-3-gallate (EGCG) is known to inhibit the Hv1
currents inmicroglial BV2 cells (Jin et al., 2012). Interestingly, the
reduction in TNF-α release produced by some antidepressants
was supposed to be related to the same effect (Song et al., 2012).
The putative role of this ionic mechanism in the LPS-induced
sterile inflammation is also currently under investigation in our
laboratory (EW, FG, and ML).
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